DK0876343T3 - Aromatiske ketosyrer og derivater deraf som inhibitorer af matrixmetalloproteinaser - Google Patents

Aromatiske ketosyrer og derivater deraf som inhibitorer af matrixmetalloproteinaser

Info

Publication number
DK0876343T3
DK0876343T3 DK96940614T DK96940614T DK0876343T3 DK 0876343 T3 DK0876343 T3 DK 0876343T3 DK 96940614 T DK96940614 T DK 96940614T DK 96940614 T DK96940614 T DK 96940614T DK 0876343 T3 DK0876343 T3 DK 0876343T3
Authority
DK
Denmark
Prior art keywords
pct
inhibitors
derivatives
matrix metalloproteinases
sec
Prior art date
Application number
DK96940614T
Other languages
Danish (da)
English (en)
Inventor
Donald Hupe
Linda Lea Johnson
Daniel Fred Ortwine
Claude Forsey Purchase Jr
Andrew David White
Qi-Zhuang Ye
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK0876343T3 publication Critical patent/DK0876343T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK96940614T 1995-12-22 1996-11-27 Aromatiske ketosyrer og derivater deraf som inhibitorer af matrixmetalloproteinaser DK0876343T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US948995P 1995-12-22 1995-12-22
PCT/US1996/018925 WO1997023459A1 (fr) 1995-12-22 1996-11-27 Ceto-acides aromatiques et leurs derives comme inhibiteurs de metalloproteinases matricielles

Publications (1)

Publication Number Publication Date
DK0876343T3 true DK0876343T3 (da) 2002-07-01

Family

ID=21737977

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96940614T DK0876343T3 (da) 1995-12-22 1996-11-27 Aromatiske ketosyrer og derivater deraf som inhibitorer af matrixmetalloproteinaser

Country Status (19)

Country Link
US (1) US6008220A (fr)
EP (1) EP0876343B1 (fr)
JP (1) JP2000502343A (fr)
AT (1) ATE214368T1 (fr)
AU (1) AU713174C (fr)
BG (1) BG63461B1 (fr)
BR (1) BR9612188A (fr)
CZ (1) CZ287868B6 (fr)
DE (1) DE69619865T2 (fr)
DK (1) DK0876343T3 (fr)
ES (1) ES2175155T3 (fr)
HU (1) HU222986B1 (fr)
NO (1) NO309470B1 (fr)
NZ (1) NZ323329A (fr)
PL (1) PL327494A1 (fr)
PT (1) PT876343E (fr)
SK (1) SK87598A3 (fr)
WO (1) WO1997023459A1 (fr)
ZA (1) ZA9610722B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500948B1 (en) 1995-12-08 2002-12-31 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof
DE69633947T2 (de) * 1995-12-08 2005-12-01 Agouron Pharmaceuticals, Inc., San Diego Zwischenprodukte zur Herstellung von Metallproteinasehemmern
US5795985A (en) * 1996-03-05 1998-08-18 Ciba Specialty Chemicals Corporation Phenyl alkyl ketone substituted by cyclic amine and a process for the preparation thereof
US6174915B1 (en) 1997-03-25 2001-01-16 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
US6008243A (en) * 1996-10-24 1999-12-28 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
EP1366765A1 (fr) * 1996-12-17 2003-12-03 Warner-Lambert Company Llc Utilisation d'inhibiteurs de métalloproteinase matricielle dans le traitement de maladies neurologiques et la cicatrisation des blessures
BR9714142A (pt) 1996-12-17 2000-02-29 Warner Lambert Co Uso de inibidores de metaloproteìnases matriciais para tratamento de distúrbios neurológicos e promoção de cicatrização de feridas
US5985900A (en) * 1997-04-01 1999-11-16 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
US6420427B1 (en) 1997-10-09 2002-07-16 Ono Pharmaceutical Co., Ltd. Aminobutyric acid derivatives
US6288063B1 (en) 1998-05-27 2001-09-11 Bayer Corporation Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
JP2006516548A (ja) 2002-12-30 2006-07-06 アンジオテック インターナショナル アクツィエン ゲゼルシャフト 迅速ゲル化ポリマー組成物からの薬物送達法
MY150088A (en) 2003-05-19 2013-11-29 Irm Llc Immunosuppressant compounds and compositions
WO2010011302A1 (fr) * 2008-07-22 2010-01-28 Chdi, Inc. Inhibiteurs de kynurénine-3-monooxygénase, compositions pharmaceutiques et leurs procédés d'utilisation
US9428464B2 (en) 2011-08-30 2016-08-30 Chdi Foundation, Inc. Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
CA2844128C (fr) 2011-08-30 2020-09-01 Chdi Foundation, Inc. Inhibiteurs de kynurenine-3-monooxygenase, compositions pharmaceutiques et procedes d'utilisation de ces compositions
AU2015289492B2 (en) 2014-07-17 2020-02-20 Chdi Foundation, Inc. Methods and compositions for treating HIV-related disorders
ES2760266T3 (es) * 2014-09-09 2020-05-13 Bristol Myers Squibb Co Moduladores de GPR120 de ácido fenil-(aza)cicloalquil carboxílico

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0821671B1 (fr) * 1995-04-20 2000-12-27 Pfizer Inc. Derives d'acide hydroxamique arylsufonyle en tant qu'inhibiteurs de mmp et de tnf
NZ334897A (en) * 1996-12-09 2001-02-23 Warner Lambert Co Medicaments for treating and preventing heart failure and ventricular dilatation
BR9714142A (pt) * 1996-12-17 2000-02-29 Warner Lambert Co Uso de inibidores de metaloproteìnases matriciais para tratamento de distúrbios neurológicos e promoção de cicatrização de feridas

Also Published As

Publication number Publication date
NO982840L (no) 1998-06-19
DE69619865D1 (de) 2002-04-18
ATE214368T1 (de) 2002-03-15
PL327494A1 (en) 1998-12-21
HU222986B1 (hu) 2004-01-28
DE69619865T2 (de) 2002-11-07
MX9803315A (es) 1998-09-30
BG63461B1 (bg) 2002-02-28
AU713174C (en) 2002-05-02
JP2000502343A (ja) 2000-02-29
PT876343E (pt) 2002-08-30
AU1024997A (en) 1997-07-17
WO1997023459A1 (fr) 1997-07-03
US6008220A (en) 1999-12-28
BR9612188A (pt) 1999-07-13
CZ287868B6 (en) 2001-02-14
HUP9902079A2 (hu) 1999-10-28
BG102471A (en) 1999-08-31
SK87598A3 (en) 1999-04-13
EP0876343B1 (fr) 2002-03-13
ZA9610722B (en) 1997-06-27
ES2175155T3 (es) 2002-11-16
AU713174B2 (en) 1999-11-25
NZ323329A (en) 1999-02-25
NO982840D0 (no) 1998-06-19
CZ195298A3 (cs) 1998-09-16
HUP9902079A3 (en) 2000-06-28
EP0876343A1 (fr) 1998-11-11
NO309470B1 (no) 2001-02-05

Similar Documents

Publication Publication Date Title
IL123901A (en) Sulfonamide inhibitors of matrix metalloproteinases and pharmaceutical compositions comprising them
DK0876343T3 (da) Aromatiske ketosyrer og derivater deraf som inhibitorer af matrixmetalloproteinaser
NO972980D0 (no) Anvendelse av nebivolol som et anti-aterogent middel
YU54896A (sh) (methilsulfonil)fenil-2-(5h)-furanoni kao cox-2 inhibitori
NZ509439A (en) Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
NO964486D0 (no) Anvendelse av visse metanbisfosfonsyrederivater for å forhindre lösning av protese og protesemigrering
BR9712794A (pt) Compostos para e um método de inibição de metaloproteinases matriciais
DK0888327T3 (da) Benzopyranderivater, som har antagonistisk virkning imod leukotriener
DK0828726T3 (da) Tricykliske inhibitorer af matrixmetalloproteinaser
DK0814791T3 (da) Aminotetralin-derivat til behandlingen af cardiovaskulære sygdomme
NO964497L (no) Middel for behandling av cor pulmonale
CA2233560A1 (fr) Inhibiteurs de metalloprotineases matricielles a base de sulfamide
ATE190845T1 (de) Rektale flunisolid-zubereitung zur behandlung entzündlicher darmerkrankungen
WO1998038985A3 (fr) Medicament pour la prophylaxie et le traitement des maladies inflammatoires
UY24693A1 (es) Ácidos bifenil butíricos y sus derivados como inhibidores de metaloproteinasas de matriz